Retraction: Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant staphylococcus aureus infection in mice with skin injuries (Antimicrobial Agents and Chemotherapy (2014) 58:3 (e02427-13) DOI: 10.1128/AAC.02427-13);Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant Staphylococcus aureus infection in mice with skin injuries

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1538-1545

  Huang, Han Ning ^a   Pan, Chieh Yu ^b   Chan, Yi Lin ^c   Chen, Jyh Yih ^b   Wu, Chang Jer ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GE 33; INTERLEUKIN 6; METICILLIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PARDAXIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VANCOMYCIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL SKIN DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; DERMIS; EPIDERMIS; EPITHELIZATION; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN INJURY; SKIN PROTECTION; SURVIVAL; WOUND CLOSURE; WOUND HEALING; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; FEMALE; FISH VENOMS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL SKIN INFECTIONS; WOUND HEALING; WOUND INFECTION;

EID: 84896895857     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00484-20     Document Type: Erratum

References (31)

1. Theuretzbacher U, Toney JH. 2006. Nature's clarion call of antibacterial resistance: are we listening? Curr. Opin. Investig. Drugs 7:158-166. (Pubitemid 43230912)
2. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards, JE, Jr. 2004. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38:1279-1286. http://dx.doi.org/10.1086/420937. (Pubitemid 38608571)
3. Rajanbabu V, Chen JY. 2011. The antimicrobial peptide, tilapia hepcidin 2-3, and PMA differentially regulate the protein kinase C isoforms, TNF-α and COX-2, in mouse RAW264.7 macrophages. Peptides 32:333-341. http://dx.doi.org/10.1016/j.peptides.2010.11.004.
4. Huang HN, Pan CY, Rajanbabu V, Chan YL, Wu CJ, Chen JY. 2011. Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine. Biomaterials 32:3627-3636. http://dx.doi.org/10.1016/j.biomaterials.2011.01.061.
5. Primor N, Tu AT. 1980. Conformation of pardaxin, the toxin of the flatfish Pardachirus marmoratus. Biochim. Biophys. Acta 626:299-306. http://dx.doi.org/10.1016/0005-2795(80)90124-5. (Pubitemid 11128522)
6. Oren Z, Shai Y. 1996. A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur. J. Biochem. 237:303-310. http://dx.doi.org/10.1111/ j.1432-1033.1996.0303n.x. (Pubitemid 26111320)
7. Oren Z, Hong J, Shai Y. 1997. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 272: 14643-14649. http://dx.doi.org/10.1074/jbc.272.23.14643. (Pubitemid 27251727)
8. Abu-Raya S, Bloch-Shilderman E, Shohami E, Trembovler V, Shai Y, Weidenfeld J, Yedgar S, Gutman Y, Lazarovici P. 1998. Pardaxin, a new pharmacological tool to stimulate the arachidonic acid cascade in PC12 cells. J. Pharmacol. Exp. Ther. 287:889-896. (Pubitemid 29131597)
9. Abu-Raya S, Bloch-Shilderman E, Lelkes PI, Trembovler V, Shohami E, Gutman Y, Lazarovici P. 1999. Characterization of pardaxin-induced dopamine release from pheochromocytoma cells: role of calcium and eicosanoids. J. Pharmacol. Exp. Ther. 288:399-406. (Pubitemid 29119644)
10. Bloch-Shilderman E, Jiang H, Abu-Raya S, Linial M, Lazarovici P. 2001. Involvement of extracellular signal-regulated kinase (ERK) in pardaxin-induced dopamine release from PC12 cells. J. Pharmacol. Exp. Ther. 296:704-711. (Pubitemid 32192851)
11. Hsu JC, Lin LC, Tzen JT, Chen JY. 2011. Pardaxin-induced apoptosis enhances antitumor activity in HeLa cells. Peptides 32:1110-1116. http://dx.doi.org/10.1016/j.peptides.2011.04.024.
12. Huang TC, Lee JF, Chen JY. 2011. Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT-1080 cells. Mar. Drugs 9:1995-2009. http://dx.doi.org/10.3390/md9101995.
13. Wu SP, Huang TC, Lin CC, Hui CF, Lin CH, Chen JY. 2012. Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in vitro and in vivo. Mar. Drugs 10:1852-1872. http://dx.doi.org/10.3390/ md10081852.
14. Shai Y, Oren Z. 1996. Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J. Biol. Chem. 271:7305-7308. http://dx.doi.org/10.1074/jbc.271.13.7305. (Pubitemid 26106994)
15. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N. Engl. J. Med. 341:738-746. http://dx.doi.org/10.1056/NEJM199909023411006. (Pubitemid 29407375)
16. Svoboda KK, Fischman DA, Gordon MK. 2008. Embryonic chick corneal epithelium: a model system for exploring cell-matrix interactions. Dev. Dyn. 237:2667-2675. http://dx.doi.org/10.1002/dvdy.21637.
17. Gopinath D, Ahmed MR, Gomathi K, Chitra K, Sehgal PK, Jayakumar R. 2004. Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 25:1911-1917. http://dx.doi.org/10.1016/S0142-9612(03)00625-2. (Pubitemid 38102266)
18. Nunes PS, Albuquerque RL, Jr, Cavalcante DR, Dantas MD, Cardoso JC, Bezerra MS, Souza JC, Serafini MR, Quitans LJ, Jr, Bonjardim LR, Araújo AA. 2011. Collagen-based films containing liposome-loaded usnic acid as dressing for dermal burn healing. J. Biomed. Biotechnol. 2011:761593. http://dx.doi.org/10.1155/2011/761593.
19. Houghton PJ, Hylands PJ, Mensah AY, Hensel A, Deters AM. 2005. In vitro tests and ethnopharmacological investigations: wound healing as an example. J. Ethnopharmacol. 100:100-107. http://dx.doi.org/10.1016/j.jep.2005.07.001. (Pubitemid 41073530)
20. Martin A. 1996. The use of antioxidants in healing. Dermatol. Surg. 22:156-160. (Pubitemid 26069621)
21. Tkalcevic VI, Cuzic S, Parnham MJ, Pasalic I, Brajsa K. 2009. Differential evaluation of excisional non-occluded wound healing in db/db mice. Toxicol. Pathol. 37:183-192. http://dx.doi.org/10.1177/0192623308329280.
22. Hebda PA, Whaley D, Kim HG, Wells A. 2003. Absence of inhibition of cutaneous wound healing in mice by oral doxycycline. Wound Repair Regen. 11:373-379. http://dx.doi.org/10.1046/j.1524-475X.2003.11510.x. (Pubitemid 37122570)
23. Babu M, Wells A. 2001. Dermal-epidermal communication in wound healing. Wounds 13:183-189.
24. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD. 2002. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 23:3661-3671. http://dx.doi.org/10.1016/S0142-9612(02)00100-X. (Pubitemid 34626569)
25. Huang HN, Rajanbabu V, Pan CY, Chan YL, Wu CJ, Chen JY. 2013. Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries. Biomaterials 34:10319-10327. http://dx.doi.org/10.1016/j. biomaterials.2013.09.037.
26. Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y, Cao Z, Li W. 2012. Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. PLoS One 7:e40135. http://dx.doi.org/10.1371/journal.pone.0040135.
27. Yates CC, Whaley D, Babu R, Zhang J, Krishna P, Beckman E, Pasculle AW, Wells A. 2007. The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. Biomaterials 28:3977-3986. http://dx.doi.org/10.1016/j.biomaterials.2007.05.008. (Pubitemid 47048361)
28. Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock RE. 2007. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25:465-472. http://dx.doi.org/10. 1038/nbt1288. (Pubitemid 46572850)
29. Fox JL. 2013. Antimicrobial peptides stage a comeback. Nat. Biotechnol. 31:379-382. http://dx.doi.org/10.1038/nbt.2572.
30. Bhunia A, Domadia PN, Torres J, Hallock KJ, Ramamoorthy A, Bhattacharjya S. 2010. NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J. Biol. Chem. 285:3883-3895. http://dx.doi.org/10.1074/jbc.M109.065672.
31. Lin MC, Hui CF, Chen JY, Wu JL. 2013. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus. Peptides 44:139-148. http://dx.doi.org/10.1016/j.peptides.2013.04.004.